Form 4: Outset Medical SVP Sells Shares to Cover Tax Obligations

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 252 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Summary

• On May 15, 2025, Marc Nash, SVP of Operations and R&D at Outset Medical, sold 252 shares of common stock at a price of $17.82 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of 673 shares of common stock underlying RSUs granted on March 15, 2023, July 24, 2023, and January 12, 2024.
• Following the transaction, Nash directly owns 13,465 shares of Outset Medical common stock, adjusted to reflect a 1-for-15 reverse stock split on March 20, 2025.
• This includes 333 shares acquired through the Outset Medical, Inc. 2020 Employee Stock Purchase Plan (ESPP) for the purchase period of September 1, 2024 to February 28, 2025.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction. It is neither particularly positive nor negative.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
• The 'sell to cover' transaction is a common method for employees to manage tax liabilities associated with equity compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale related to tax obligations.

Key Dates

Keywords

Outset Medical, Marc Nash, stock sale, Form 4, RSUs, tax withholding, ESPP, reverse stock split